Search
Spotlight
Practice Pearls
Women's Health
Zoster
Practice Pearls
Women's Health
Zoster
Clinical Role
View More
Hospital
Oncology
Pharmacy Technician
Retail
Specialty Pharmacy
Student
Hospital
Oncology
Pharmacy Technician
Retail
Specialty Pharmacy
Student
Clinical
View More
Allergy
Brain Health
Breast Cancer
Cardiovascular Health
Coronavirus
Cough and Cold
Diabetes
Flu
Hematology
Immunization
Infectious Disease
Neurology
Pain Management
Vitamins and Supplements
Allergy
Brain Health
Breast Cancer
Cardiovascular Health
Coronavirus
Cough and Cold
Diabetes
Flu
Hematology
Immunization
Infectious Disease
Neurology
Pain Management
Vitamins and Supplements
News
All News
Press Releases
All News
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Student Voices
Webinars/Webcasts
All Videos
Digital Detail
Independent Corner
Insights
Interviews
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Publications
Events
Upcoming Events
Upcoming Webinars
Upcoming Events
Upcoming Webinars
CME/CE
Resources
Cou-Co
Educated Patient
Interactive Tools
Partners
Sponsored
Cou-Co
Educated Patient
Interactive Tools
Partners
Sponsored
Subscribe
Search
Spotlight
Practice Pearls
Women's Health
Zoster
Clinical Role
See All >
Hospital
Oncology
Pharmacy Technician
Retail
Specialty Pharmacy
Student
Clinical
See All >
Allergy
Brain Health
Breast Cancer
Cardiovascular Health
Coronavirus
Cough and Cold
Diabetes
Flu
Hematology
Immunization
Infectious Disease
Neurology
Pain Management
Vitamins and Supplements
Peer Exchange
All Series
Adoption of Oncology Biosimilars into Clinical Practice
EP. 1: Overview of Biosimilars in Oncology
EP. 2: Interchangeability of Biosimilars
EP. 3: Role of Immunogenicity in Biosimilars
EP. 4: Using Secondary Patents and Skinny Labels
EP. 5: Adopting Biosimilars in Clinical Practice
The Opioid Crisis: A Multidisciplinary Perspective on Effective Management
EP. 1: Current State of the Opioid Crisis: Multifaceted Point of View
EP. 2: Unmet Needs and the Impact of COVID-19 on the Opioid Crisis
EP. 3: Effective and Appropriate Pain Management Challenges
EP. 4: Opioid Crisis Misconceptions and Unintended Consequences
EP. 5: Risks for Accidental Opioid Overdose Seen in the Community
EP. 6: New Labeling Requirements Put Forth by the FDA for Opioids
EP. 7: Implementing Protocols, Policies, and Programs to Save Lives
EP. 8: Improving the Accessibility of Naloxone and Potential Impact
EP. 9: Normalizing the Conversation about Naloxone with the Public
EP. 10: Barriers to Naloxone Prescribing, Dispensing, and Utilization
EP. 11: December 2020 CDC Health Alert Highlights and Implementation
EP. 12: Are Recommendations Infringing Upon Practice Autonomy?
Current and Future Considerations in the Treatment of Relapsed/Refractory Multiple Myeloma
EP. 1: Relapsed/Refractory Multiple Myeloma: Disease Overview
EP. 2: Treatment Pathways for Relapsed/Refractory Myeloma
EP. 3: IV Versus Subcutaneous Daratumumab
EP. 4: Backbone Regimens for Relapsed/Refractory Myeloma
EP. 5: mAb-based Therapies for Relapsed/Refractory Myeloma
EP. 6: Novel Agents for Relapsed/Refractory Myeloma
EP. 7: Belantamab Mafodotin for RRMM
EP. 8: RRMM: Adopting Anti-BCMA Therapy into Practice
EP. 9: RRMM: Educating Pharmacists on Anti-BCMA Therapy
EP. 10: Clinical Trials of Interest in RRMM
EP. 11: Optimizing Therapy for Patients With RRMM
Expert Perspectives on Advances in the Management of C. Difficile
EP. 1: C. Difficile Risk Factors and Manifestation
EP. 2: Strains of C. Difficile
EP. 3: Managing Community-Onset C. Difficile
EP. 4: Recurrent C. Difficile
EP. 5: C. Difficile: A Differential Diagnosis
EP. 6: Testing for C. Difficile Infections
EP. 7: Screening for C. Difficile
EP. 8: C. Difficile: Clinical Practice Guidelines and Treatment Options
EP. 9: C. Difficile: Updates to Clinical Practice Guidelines
EP. 10: Selecting Therapy to Treat C. Difficile
EP. 11: C. Difficile Treatment: Fidaxomicin
EP. 12: Choosing Between Vancomycin and Fidaxomicin for C. Difficile Infections
Advancements in the Management of Immune Thrombocytopenia
EP. 1: Immune Thrombocytopenia Defined
EP. 2: Immune Thrombocytopenia: Risks and Impact on Patients
EP. 3: Immune Thrombocytopenia: A Differential Diagnosis
EP. 4: Initial Treatment of Immune Thrombocytopenia
EP. 5: Corticosteroids Vs IVIG for Immune Thrombocytopenia
EP. 6: Unmet Needs in the Treatment of Immune Thrombocytopenia
EP. 7: Sequencing Therapy in ITP: Current Guidelines
EP. 8: SYK Inhibitors as Immune Thrombocytopenia Treatment
EP. 9: Immune Thrombocytopenia: SYK Inhibitors and COVID-19
EP. 10: What to Know When Treating ITP With a SYK Inhibitor
EP. 11: SYK Inhibitors to Treat ITP: Clinical Implications
EP. 12: TPO-RAs as Immune Thrombocytopenia Treatment
EP. 13: Combination Therapy for Immune Thrombocytopenia Treatment
EP. 14: Immune Thrombocytopenia Treatment: Rituximab and Splenectomy
The Role for Biosimilars in Oncology
EP. 1: Comparison of Biosimilars vs Biologic Agents
EP. 2: FDA Approval Process of Biosimilars
EP. 3: Interchangeability Status in Biosimilars
EP. 4: Efficacy of Biosimilars vs Biologics
EP. 5: Role of Biosimilars in US vs Europe
EP. 6: Impact of Biosimilars on Cancer Treatment
EP. 7: Currently Available Biosimilars in the US
EP. 8: Current and Next-Generation Biosimilars in Oncology
EP. 9: Clinical Experiences for Biosimilars in Oncology
EP. 10: Biosimilar Decision-Making Process in Clinical Settings
EP. 11: Recommending Biosimilars vs Biologics: Patient Factors
EP. 12: Switching Treatment From Biologics to Biosimilars
EP. 13: Limiting Quantity of Available Biosimilars
EP. 14: Role of Clinical Pharmacists in Switching Biosimilars
EP. 15: Provider Education on Biosimilar Products
EP. 16: Raising Patient Awareness of Biosimilar Products
EP. 17: Myths and Misconceptions on Biosimilars
EP. 18: Economic Impact of Biosimilars
EP. 19: Impact of Competition of Biosimilars on Biologics